|
|
Volumn 166, Issue 2, 2003, Pages 411-412
|
|
Apolipoprotein B-100 gene mutations and cholesterol control in German patients [3]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
APOLIPOPROTEIN B100;
ARGININE;
CHOLESTEROL;
CYSTEINE;
GLUTAMINE;
LIGAND;
LOW DENSITY LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN RECEPTOR;
ATHEROSCLEROSIS;
AWARENESS;
FAMILY HISTORY;
GENE MUTATION;
GENERAL PRACTITIONER;
GERMANY;
HEALTH PROGRAM;
HEART INFARCTION;
HUMAN;
INFORMED CONSENT;
LETTER;
MEDICAL ASSESSMENT;
PATIENT;
PRIORITY JOURNAL;
PROFESSIONAL STANDARD;
REHABILITATION CENTER;
STATISTICAL SIGNIFICANCE;
ADOLESCENT;
ADULT;
AGE DISTRIBUTION;
AGED;
ANALYSIS OF VARIANCE;
ANTILIPEMIC AGENTS;
APOLIPOPROTEIN B-100;
APOLIPOPROTEINS B;
CHILD;
CHILD, PRESCHOOL;
CHOLESTEROL, LDL;
CORONARY ARTERIOSCLEROSIS;
FEMALE;
GENE FREQUENCY;
GENETIC MARKERS;
GERMANY;
HUMANS;
HYPERLIPOPROTEINEMIA TYPE II;
INCIDENCE;
INFANT;
MALE;
MASS SCREENING;
MIDDLE AGED;
MUTATION;
POLYMERASE CHAIN REACTION;
PROBABILITY;
RISK ASSESSMENT;
SEX DISTRIBUTION;
|
|
EID: 0037298523
PISSN: 00219150
EISSN: None
Source Type: Journal
DOI: 10.1016/S0021-9150(02)00377-5 Document Type: Letter |
|
Times cited : (4)
|
|
References (3)
|
